Find out how Apple and Fitbit are stepping further into health care, how data may be an important tool in the fight against opioid deaths, and more.
Two competitors in the wearables space — Apple and Fitbit — recently announced they’re testing new capabilities in the health care space. Apple teamed up with clinicians from Stanford and telemedicine provider American Well to see if Apple Watch can detect heart problems, CNBC reports. Fitbit, on the other hand, is working with Dexcom to develop a wearable glucose monitoring system, TechCrunch reports.
Researchers at the University of Southern California’s Center for Body Computing explore why people abandon or stick with their wearable devices. Most people ramp up activity levels after getting a device, but a third stop tracking six months later. The researchers attempt to spot the factors that might determine whether people stick with it. Read the article in NEJM Catalyst.
To get a real-time view of the opioid epidemic in their state, Indiana public health officials are pooling data from state agencies, local police departments, hospitals, pharmacies, mental-health agencies and others. The database is allowing them, for example, to identify gaps in access to treatment centers near overdose hotspots. Read the story in Wired.
The Food and Drug Administration approved reSET, a mobile app made by Pear Therapeutics, on Sept. 14. It’s the first substance abuse disorder treatment app to earn federal approval. The app uses a digitized version of cognitive behavioral therapy to treat people struggling with tobacco, alcohol and drug abuse. The version reviewed by the FDA was not approved to treat opioid dependence. Read the full story from CNBC here.
Artificial intelligence is poised to make a big splash in the health care industry, with the ability to assist doctors with diagnoses and interpret genomic data in a flash. Becker’s Hospital Review compiled nine AI-related terms for industry leaders to know. Read them here.